Clinical Trial Update: Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 open-label pilot and feasibility study of niacinamide for polycystic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Disease

Drugs mentioned

• Niacinamide (nicotinamide)

Snippet

Sponsor: Alan Yu, MB, BChir | Conditions: Polycystic Kidney Disease | Phase 2 | Status: COMPLETED